Overview

Effect and Safety Study of Atorvastatin to Treat Chronic Subdural Hematoma

Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
To evaluate the clinic effects and security of oral administration of Atorvastatin on chronic subdural hematoma (CSDH).
Phase:
Phase 2
Details
Lead Sponsor:
Oriental Neurosurgery Evidence-Based-Study Team
Treatments:
Atorvastatin
Atorvastatin Calcium